This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2 UC Yadav , K Moorthy & NZ Baquer (2005) Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell Biochem 268, 111–120.
4 GV Senanayake , M Maruyama , K Shibuya , M Sakono , N Fukuda , T Morishita , C Yukizaki , M Kawano & H Ohta (2004) The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. J Ethnopharmacol 91, 257–262.
5 GV Senanayake , M Maruyama , M Sakono , N Fukuda , T Morishita , C Yukizaki , M Kawano & H Ohta (2004) The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterol-enriched diets. J Nutr Sci Vitaminol (Tokyo) 50, 253–257.
6 P Chaturvedi , S George , M Milinganyo & YB Tripathi (2004) Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytother Res 18, 954–956.
8 J Virdi , S Sivakami , S Shahani , AC Suthar , MM Banavalikar & MK Biyani (2003) Antihyperglycemic effects of three extracts from Momordica charantia. J Ethnopharmacol 88, 107–111.
10 A Carpentier , C Taghibiglou , N Leung , L Szeto , SC Van Iderstine , KD Uffelman , R Buckingham , K Adeli & GF Lewis (2002) Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277, 28795–28802.
11 JD Sparks , TL Phung , M Bolognino & CE Sparks (1996) Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem J 313, 567–574.
12 RK Avramoglu & K Adeli (2004) Hepatic regulation of apolipoprotein B. Rev Endocr Metab Disord 5, 293–301.
13 T Chong , M Naples , L Federico , D Taylor , GJ Smith , RC Cheung & K Adeli (2006) Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia. Atherosclerosis 185, 21–31.
14 C Taghibiglou , F Rashid-Kolvear , SC Van Iderstine , H Le-Tien , IG Fantus , GF Lewis & K Adeli (2002) Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and over expression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 277, 793–803.
16 SK Raj , MS Khan , R Singh , N Kumari & D Prakash (2005) Occurrence of yellow mosaic geminiviral disease on bitter gourd (Momordica charantia) and its impact on phytochemical contents. Int J Food Sci Nutr 56, 185–192.
17 PK Saha , H Kojima , J Martinez-Botas , AL Sunehag & L Chan (2004) Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J Biol Chem 279, 35150–35158.
18 K Scribner , T Gadbois , M Gowri , S Azhar & G Reaven (2000) Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia. Metabolism 49, 1106–1110.
19 DY Hui (2003) HIV protease inhibitors and atherosclerosis. J Clin Invest 111, 317–318.
20 C Messier , K Whately , J Liang , L Du & D Puissant (2007) The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL/6 mice. Behav Brain Res 178, 139–145.
21 RK Avramoglu , H Basciano & K Adeli (2006) Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 368, 1–19.
23 PV Nerurkar , YK Lee , EH Linden , S Lim , L Pearson , J Frank & VR Nerurkar (2006) Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2. Br J Pharmacol 148, 1156–1164.
24 PR Shepherd , DJ Withers & K Siddle (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. Biochem J 333, 471–490.
25 N Arimura , T Horiba , M Imagawa , M Shimizu & R Sato (2004) The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. J Biol Chem 279, 10070–10076.
26 K Ueki , DA Fruman , CM Yballe , M Fasshauer , J Klein , T Asano , LC Cantley & CR Kahn (2003) Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 278, 48453–48466.
27 D Patsouris , JK Reddy , M Muller & S Kersten (2006) Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 147, 1508–1516.
28 C Ameen , U Edvardsson , A Ljungberg , L Asp , P Akerblad , A Tuneld , SO Olofsson , D Linden & J Oscarsson (2005) Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver. J Biol Chem 280, 1224–1229.
29 CY Chao & CJ Huang (2003) Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and up regulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J Biomed Sci 10, 782–791.
30 AP Jayasooriya , M Sakono , C Yukizaki , M Kawano , K Yamamoto & N Fukuda (2000) Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J Ethnopharmacol 72, 331–336.
31 I Ahmed , MS Lakhani , M Gillett , A John & H Raza (2001) Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 51, 155–161.
32 S Abd El Sattar El Batran , SE El-Gengaihi & OA El Shabrawy (2006) Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol 108, 236–242.
33 P Khanna , SC Jain , A Panagariya & VP Dixit (1981) Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod 44, 648–655.
34 I Jantan , IA Rafi & J Jalil (2005) Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants. Phytomedicine 12, 88–92.
35 L Anila & NR Vijayalakshmi (2000) Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res 14, 592–595.
36 L Harinantenaina , M Tanaka , S Takaoka , M Oda , O Mogami , M Uchida & Y Asakawa (2006) Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull (Tokyo) 54, 1017–1021.
37 J Welihinda , EH Karunanayake , MH Sheriff & KS Jayasinghe (1986) Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 17, 277–282.
38 BA Leatherdale , RK Panesar , G Singh , TW Atkins , CJ Bailey & AH Bignell (1981) Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J (Clin Res Ed) 282, 1823–1824.
39 Y Srivastava , H Venkatakrishna-Bhatt , Y Verma , (1993) Antidiabetic and adaptogenic properties of Momordica charantia extract. An experimental and clinical evaluation. Phytother Res 7, 285–289.
41 MK Tuekpe , H Todoriki , S Sasaki , KC Zheng & M Ariizumi (2006) Potassium excretion in healthy Japanese women was increased by a dietary intervention utilizing home-parcel delivery of Okinawan vegetables. Hypertens Res 29, 389–396.